215 related articles for article (PubMed ID: 31652035)
1. Nicotinamide N-methyltransferase expression and its association with phospho-Akt, p53 expression, and survival in high-grade endometrial cancer.
Akar S; Harmankaya İ; Uğraş S; Çelik Ç
Turk J Med Sci; 2019 Oct; 49(5):1547-1554. PubMed ID: 31652035
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma.
Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF
Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801
[TBL] [Abstract][Full Text] [Related]
4. Expression and Clinical Significance of Nicotinamide N-Methyltransferase in Cervical Squamous Cell Carcinoma.
Akar S; Harmankaya İ; Uğraş S; Çelik Ç
Int J Gynecol Pathol; 2020 May; 39(3):289-295. PubMed ID: 31033801
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
[TBL] [Abstract][Full Text] [Related]
6. Lipid reprogramming induced by the NNMT-ABCA1 axis enhanced membrane fluidity to promote endometrial cancer progression.
Wen Q; Xie X; Chen C; Wen B; Liu Y; Zhou J; Lin X; Jin H; Shi K
Aging (Albany NY); 2023 Oct; 15(21):11860-11874. PubMed ID: 37889548
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
Yang J; Tong Q; Zhang Y; Yuan S; Gao Y; Deng K; Wang Y; Lu J; Xie X; Zhang Z; Zhang J
J Cancer; 2021; 12(20):6170-6181. PubMed ID: 34539890
[No Abstract] [Full Text] [Related]
8. Nicotinamide N-methyltransferase expression in squamous cell carcinoma of the vulva.
Çelik ZE; Akar S; Fındık S; Aytekin E; Çelik Ç
J Obstet Gynaecol; 2022 Aug; 42(6):2325-2330. PubMed ID: 35499473
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide N-methyltransferase is related to MELF pattern invasion in endometrioid carcinoma.
Tahara S; Nojima S; Ohshima K; Hori Y; Sato K; Kurashige M; Matsui T; Okuzaki D; Morii E
Cancer Med; 2021 Dec; 10(23):8630-8640. PubMed ID: 34655178
[TBL] [Abstract][Full Text] [Related]
10. P53/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome.
Jeczen R; Skomra D; Cybulski M; Schneider-Stock R; Szewczuk W; Roessner A; Rechberger T; Semczuk A
Clin Exp Metastasis; 2007; 24(7):503-11. PubMed ID: 17671841
[TBL] [Abstract][Full Text] [Related]
11. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
12. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.
Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS
J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803
[TBL] [Abstract][Full Text] [Related]
13. Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer.
Ogawa M; Tanaka A; Namba K; Shia J; Wang JY; Roehrl MHA
Sci Rep; 2022 Feb; 12(1):2767. PubMed ID: 35177765
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells.
Xie X; Yu H; Wang Y; Zhou Y; Li G; Ruan Z; Li F; Wang X; Liu H; Zhang J
Arch Biochem Biophys; 2014 Dec; 564():52-66. PubMed ID: 25201588
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation.
Seta R; Mascitti M; Campagna R; Sartini D; Fumarola S; Santarelli A; Giuliani M; Cecati M; Muzio LL; Emanuelli M
Clin Oral Investig; 2019 Feb; 23(2):829-838. PubMed ID: 29882109
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells.
Tang SW; Yang TC; Lin WC; Chang WH; Wang CC; Lai MK; Lin JY
Carcinogenesis; 2011 Feb; 32(2):138-45. PubMed ID: 21045016
[TBL] [Abstract][Full Text] [Related]
17. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer.
Li J; Yue H; Yu H; Lu X; Xue X
BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144
[TBL] [Abstract][Full Text] [Related]
18. Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma.
Soslow RA; Shen PU; Chung MH; Isacson C
Int J Gynecol Pathol; 1998 Apr; 17(2):129-34. PubMed ID: 9553809
[TBL] [Abstract][Full Text] [Related]
19. Expression profile and prognostic value of NNMT in patients with pancreatic cancer.
Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J
Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.
Ganzetti G; Sartini D; Campanati A; Rubini C; Molinelli E; Brisigotti V; Cecati M; Pozzi V; Campagna R; Offidani A; Emanuelli M
Melanoma Res; 2018 Apr; 28(2):82-88. PubMed ID: 29420365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
